Hudson Bay Capital Management
SLS icon

Hudson Bay Capital Management’s SELLAS Life Sciences SLS Stock Holding History

Hudson Bay Capital Management’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-20,660
Closed -$22.3K – 1637
2025
Q1 		$22.3K Buy
+20,660
New +$24.5K ﹤0.01% 1220

Other funds holding SLS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Hudson Bay Capital Management's SLS Position: Q2 2025 in Review

Hudson Bay Capital Management sold out of SELLAS Life Sciences (SLS) in Q2 2025, closing a stake of 20,660 shares — an estimated $22.3K sold.

Hudson Bay Capital Management first reported a position in SLS in Q1 2025 and held it in 1 quarter. The position peaked at $22.3K in Q1 2025. 79 funds tracked by Wall St. Rank hold SLS as of Q2 2025.

  • Hudson Bay Capital Management reported no remaining SELLAS Life Sciences position as of Q2 2025 after selling out during the quarter.
  • Hudson Bay Capital Management sold 20,660 SELLAS Life Sciences shares in Q2 2025, an estimated $22.3K.
  • Hudson Bay Capital Management first reported a position in SELLAS Life Sciences in Q1 2025 and held it in 1 quarter.
  • Hudson Bay Capital Management's SELLAS Life Sciences position peaked at $22.3K in Q1 2025.
  • 79 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q2 2025.

Based on Hudson Bay Capital Management's 13F filing for Q2 2025, filed 14 Aug 2025.